Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
-
621
-
622
-
623
Histopathological changes in pre-treated group, treated group and normal diet group.
Published 2025Subjects: -
624
-
625
-
626
-
627
-
628
-
629
Comparison of absolute and relative errors.
Published 2025“…A significant reduction in both error types is observed, with the relative error |<i>X</i><sub><i>r</i></sub>| decreasing from approximately 10<sup>−1</sup> to 10<sup>−8</sup>. …”
-
630
Rate of convergence for relative errors.
Published 2025“…A significant reduction in both error types is observed, with the relative error |<i>X</i><sub><i>r</i></sub>| decreasing from approximately 10<sup>−1</sup> to 10<sup>−8</sup>. …”
-
631
Primer sequences and information.
Published 2025“…Through bioinformatics analysis, TRIM37 was found to be significantly downregulated in MS patients. <i><i>In vitro</i></i> experiments demonstrated that overexpression <i>TRIM37</i> could stabilize PEX5 protein via non-degradative monoubiquitination, thereby maintaining peroxisomal metabolic function, reducing oxidative stress levels, significantly decreasing apoptosis in both oligodendrocytes and neurons, and promoting the expression of myelin basic protein (MBP). …”
-
632
-
633
-
634
Time Course of the RAAS.
Published 2025“…REN levels increased significantly from baseline at 1-month visit (4.15 ± 7.35 vs. 2.75 ± 8.03 ng/L; DKD vs. non-DKD; between-group difference, <i>p</i> < 0.05), while ARR values decreased significantly from baseline at 1-month visit (−0.70 ± 1.16 vs. −0.59 ± 1.19; between‑group difference, <i>p</i> > 0.05) and 3-month visit (−0.45 ± 1.15 vs. −0.42 ± 1.07; between‑group difference, <i>p</i> > 0.05) in both groups (within‑group change vs. baseline, <i>p</i> < 0.017). …”
-
635
-
636
-
637
-
638
-
639
-
640